Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2003

01.08.2003 | Case Report

Preliminary experience offering oocyte donation to human immunodeficiency virus-1 serodiscordant couples

verfasst von: Joseph E. Peña, Melvin H. Thornton, Mark V. Sauer

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2003

Einloggen, um Zugang zu erhalten

Abstract

Case report.

Our preliminary experience on the use of donor oocytes in human immunodeficiency virus-1 (HIV-1) serodiscordant couples who have previously failed conventional in vitro fertilization (IVF) therapy is presented. Five HIV-1 serodiscordant couples in which the male is infected and the female is seronegative underwent IVF with intracytoplasmic sperm injection (ICSI) utilizing donor oocytes with day 3 embryo transfer and cryopreservation. Six oocyte donation cycles in the five couples yielded 16.8±9.5 (mean±SD) (range 11–34) oocytes; 3.8±0.4 (range 3–4) transferred embryos; and 1.8±2.2 (range 0–5) cryopreserved embryos per attempt. The fertilization rate from ICSI was 0.60±0.16 (range 0.40–0.88). Three of five couples conceived; two from one attempt (one singleton pregnancy and one twin pregnancy); and another after a failed fresh cycle using cryopreserved embryos. All female recipients tested remained seronegative 3 and 6 months post-embryo transfer. All babies (n=4) were seronegative at birth and 3 months postpartum.

Conclusion.

Oocyte donation may be considered as an alternative for childbearing in HIV serodiscordant couples in whom conventional IVF has failed due to factors inherent to the female partner.
Literatur
1.
Zurück zum Zitat ACOG Committee Opinion Committee on Ethics (2001) Human immunodeficiency virus: ethical guidelines for obstetricians and gynecologists. Obstet Gynecol 97 [Suppl]:1–6 ACOG Committee Opinion Committee on Ethics (2001) Human immunodeficiency virus: ethical guidelines for obstetricians and gynecologists. Obstet Gynecol 97 [Suppl]:1–6
2.
Zurück zum Zitat ASRM Ethics Committee (2002) Human immunodeficiency virus and infertility treatment. Fertil Steril 77:218–222CrossRefPubMed ASRM Ethics Committee (2002) Human immunodeficiency virus and infertility treatment. Fertil Steril 77:218–222CrossRefPubMed
3.
Zurück zum Zitat Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL et al (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331:1173–1180PubMed Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL et al (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331:1173–1180PubMed
4.
Zurück zum Zitat Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:1149–1153CrossRefPubMed Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:1149–1153CrossRefPubMed
5.
Zurück zum Zitat International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies. N Engl J Med 340:977–987PubMed International Perinatal HIV Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies. N Engl J Med 340:977–987PubMed
6.
Zurück zum Zitat Lassalle B, Testart J, Renard JP (1985) Human embryo features that influence the success of cryopreservation with the use of 1,2 propanediol. Fertil Steril 44:645–651PubMed Lassalle B, Testart J, Renard JP (1985) Human embryo features that influence the success of cryopreservation with the use of 1,2 propanediol. Fertil Steril 44:645–651PubMed
7.
Zurück zum Zitat Loutradis D, Drakakis P, Kallianidis K, Patsoula E, Bletsa R, Michalas S (2001) Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men. Fertil Steril 75:210–212CrossRefPubMed Loutradis D, Drakakis P, Kallianidis K, Patsoula E, Bletsa R, Michalas S (2001) Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men. Fertil Steril 75:210–212CrossRefPubMed
8.
Zurück zum Zitat Marina S, Marina F, Alcolea R, Exposito R, Huguet J, Nadal J, Verges A (1998) Human immunodeficiency virus type 1—serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril 70:35–39CrossRefPubMed Marina S, Marina F, Alcolea R, Exposito R, Huguet J, Nadal J, Verges A (1998) Human immunodeficiency virus type 1—serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril 70:35–39CrossRefPubMed
9.
Zurück zum Zitat Marina S, Marina F, Alcolea R, Nadal J, Exposito R, Huguet J (1998) Pregnancy following intracytoplasmic sperm injection from an HIV-1-seropositive man. Hum Reprod 13:3247–3249CrossRefPubMed Marina S, Marina F, Alcolea R, Nadal J, Exposito R, Huguet J (1998) Pregnancy following intracytoplasmic sperm injection from an HIV-1-seropositive man. Hum Reprod 13:3247–3249CrossRefPubMed
10.
Zurück zum Zitat Palermo GD, Cohen J, Alikani M, Adler A, Rosenwaks Z (1995) Development and implementation of intracytoplasmic sperm injection (ICSI). Reprod Fertil Dev 7:211–217PubMed Palermo GD, Cohen J, Alikani M, Adler A, Rosenwaks Z (1995) Development and implementation of intracytoplasmic sperm injection (ICSI). Reprod Fertil Dev 7:211–217PubMed
11.
Zurück zum Zitat Sauer MV, Chang PL (2002) Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. Am J Obstet Gynecol 186:627–633CrossRefPubMed Sauer MV, Chang PL (2002) Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. Am J Obstet Gynecol 186:627–633CrossRefPubMed
12.
Zurück zum Zitat Sauer MV, Paulson RJ, Ary BA, Lobo RA (1994) Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates. J Assist Reprod Genet 11:92–96PubMed Sauer MV, Paulson RJ, Ary BA, Lobo RA (1994) Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates. J Assist Reprod Genet 11:92–96PubMed
13.
Zurück zum Zitat Sauer MV, Paulson RJ, Lobo RA (1995) Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril 64:111–115PubMed Sauer MV, Paulson RJ, Lobo RA (1995) Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril 64:111–115PubMed
14.
Zurück zum Zitat Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, Albani E, Oneta M, Pardi G (1992) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340:1317–1319PubMed Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, Albani E, Oneta M, Pardi G (1992) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340:1317–1319PubMed
15.
Zurück zum Zitat Semprini AE, Fiore S, Pardi G (1997) Reproductive counselling for HIV-discordant couples. Lancet 349:1401–1402 Semprini AE, Fiore S, Pardi G (1997) Reproductive counselling for HIV-discordant couples. Lancet 349:1401–1402
16.
Zurück zum Zitat Veeck L (1991) Atlas of human oocyte and early conceptus. Williams and Wilkins, Baltimore, pp 121–150 Veeck L (1991) Atlas of human oocyte and early conceptus. Williams and Wilkins, Baltimore, pp 121–150
Metadaten
Titel
Preliminary experience offering oocyte donation to human immunodeficiency virus-1 serodiscordant couples
verfasst von
Joseph E. Peña
Melvin H. Thornton
Mark V. Sauer
Publikationsdatum
01.08.2003
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2003
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-002-0458-5

Weitere Artikel der Ausgabe 3/2003

Archives of Gynecology and Obstetrics 3/2003 Zur Ausgabe

Case Report

Ovarian osteoma

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

13.05.2024 Assistierte Reproduktion Nachrichten

Reproduktionsmedizinische Techniken haben theoretisch das Potenzial, den epigenetischen Code zu verändern und somit das Krebsrisiko der Kinder zu erhöhen. Zwischen Embryotransfer und Leukämie scheint sich ein solcher Zusammenhang bestätigt zu haben.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.